AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
The summary is based on the profile data provided by the investor
John Gustofson
CEO (Chief Executive Officer)
Scott Brun
CEO (Chief Executive Officer)
Jessica Verrilli
General Partner
Vijaya Gadde
Angel
John Gustofson
CEO (Chief Executive Officer)
Scott Brun
CEO (Chief Executive Officer)
Jessica Verrilli
General Partner
Vijaya Gadde
Angel
Katie Stanton
Angel, Founder, & General Parter
Chloe Sladden
Angel, Founding Partner
April Underwood
Angel, Chief Product Officer
Margarita Chavez
Managing Director
Monique Woodard
Founding Partner & Managing Director
Jana Messerschmidt
Investor
followed by: